Riccardo M. Fumagalli

Randomized, double-blind, phase III, controlled trial comparing levobupivacaine 0.25%, ropivacaine 0.25% and bupivacaine 0.25% by the caudal route in children †

Bruno Guido Locatelli, Pablo Ingelmo, Valter Sonzogni et al. · British Journal of Anaesthesia · 2004 · 100 citations · Full text

Medicine, Anesthesiology, Pediatrics +16

Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID‐19 pneumonia

M. Cazzaniga, Luca Fumagalli, L. D’Angelo et al. · International Journal of Clinical Practice · 2021 · 54 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

Davide Voci, Andrea Götschi, Ulrike Held et al. · Thrombosis Research · 2022 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

Nicola Potere, Stefano Barco, Isabelle Mahé et al. · Journal of Thrombosis and Haemostasis · 2022 · 14 citations · Full text

Public Health, Health Education, Oncology +14

Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial

Stefano Barco, Houman Jalaie, Tim Sebastian et al. · Circulation · 2025 · 13 citations · Full text

Medicine, Pharmacotherapy, Surgery +14